Is a complete LCTX research report available?

No complete published report is available for Lineage Cell Therapeutics, Inc. (LCTX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Lineage Cell Therapeutics, Inc. (LCTX)

NYSEAMERICAN: LCTX · USD

$1.04

+0.01 (+1.0%)· Recorded snapshot

Market cap	263M
Revenue (ttm)	13.1M
Net income (ttm)	-32.3M
EPS (ttm)	-$0.19
Shares out	252.9M
Volume	997,820
Beta	1.60

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 13.1M
Net income (ttm): -32.3M
EPS (ttm): -$0.19
Market cap: 263M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	持有

Metric	Value
Amount currency	USD
CIK code	0000876343
Company name	Lineage Cell Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	53566P109
Earnings date	2026-11-09
Earnings time	amc
Employees	77
Employees change	2
Employees growth	2.67%
Enterprise value	$214.5M
Exchange	NYSEAMERICAN
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1990
In index	RUSSELL2000
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US53566P1093
Last 10-K release date	2026-03-05
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	1997-10-31
Last stock split type	Forward
Market cap	$263M
Market cap category	Micro-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$1.04
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	LCTX
U.S. state	California
Website	https://www.lineagecell.com

Metric

Value

Amount currency

USD

CIK code

0000876343

Company name

Lineage Cell Therapeutics, Inc.

Country

United States

Country code

CUSIP number

53566P109

Earnings date

2026-11-09

Earnings time

amc

Employees

Employees change

Employees growth

2.67%

Enterprise value

$214.5M

Exchange

NYSEAMERICAN

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1990

In index

RUSSELL2000

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US53566P1093

Last 10-K release date

2026-03-05

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split date

1997-10-31

Last stock split type

Forward

Market cap

$263M

Market cap category

Micro-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$1.04

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

LCTX

U.S. state

California

Website

https://www.lineagecell.com

Metric	Value
Earnings yield	-17.84%
EV/Sales	16.2x
FCF / EV yield	-11.51%
FCF yield	-9.36%
Forward EV/Sales	13.76x
Forward P/S	16.9x
P/B ratio	4.28x
P/S ratio	19.91x
Price / tangible book value	14.05x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-17.84%

EV/Sales

16.2x

FCF / EV yield

-11.51%

FCF yield

-9.36%

Forward EV/Sales

13.76x

Forward P/S

16.9x

P/B ratio

4.28x

P/S ratio

19.91x

Price / tangible book value

14.05x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	-205.23%
EBITDA margin	-199.58%
Gross margin	-57.36%
Operating margin	-205.23%
Pretax margin	-285.75%
Profit margin	-246.58%
Profit per employee	$-418,961
Profitable quarters	1
Revenue per employee	$169,909
ROA	-17.04%
ROA (5Y)	-13.52%
ROCE	-27.34%
ROE	-60.06%
ROE (5Y)	-48.6%
ROIC	-238.29%
SBC / revenue	38.75%
Tax / revenue	-40.36%

Metric

Value

EBIT margin

-205.23%

EBITDA margin

-199.58%

Gross margin

-57.36%

Operating margin

-205.23%

Pretax margin

-285.75%

Profit margin

-246.58%

Profit per employee

$-418,961

Profitable quarters

Revenue per employee

$169,909

ROA

-17.04%

ROA (5Y)

-13.52%

ROCE

-27.34%

ROE

-60.06%

ROE (5Y)

-48.6%

ROIC

-238.29%

SBC / revenue

38.75%

Tax / revenue

-40.36%

Metric	Value
EPS growth quarters	1
EPS growth years	0
Net income growth quarters	1
Net income growth years	0
Revenue growth	19.87%
Revenue growth (Q)	-61.34%
Revenue growth (QoQ)	-38.03%
Revenue growth 10Y	6.29%
Revenue growth 3Y	7.52%
Revenue growth 5Y	48.22%
Revenue growth years	2

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth

19.87%

Revenue growth (Q)

-61.34%

Revenue growth (QoQ)

-38.03%

Revenue growth 10Y

6.29%

Revenue growth 3Y

7.52%

Revenue growth 5Y

48.22%

Revenue growth years

Metric	Value
Capital expenditures	$-574,000
Depreciation and amortization	$739,000
EBIT	$-26.9M
EBITDA	$-26.1M
EPS	$-0.19
FCF per share	$-0.10
Financing cash flow	$32.2M
Free cash flow	$-24.4M
Free cash flow minus SBC	$-29.5M
Gross profit	$-7.5M
Income taxes	$-5.3M
Investing cash flow	$-13.7M
Net borrowing	$-54,000
Net cash flow	$-4.9M
Net income	$-32.3M
Operating cash flow minus SBC	$-28.9M
Operating income	$-26.9M
Revenue	$13.1M
Stock-based compensation	$5.1M

Metric

Value

Capital expenditures

$-574,000

Depreciation and amortization

$739,000

EBIT

$-26.9M

EBITDA

$-26.1M

EPS

$-0.19

FCF per share

$-0.10

Financing cash flow

$32.2M

Free cash flow

$-24.4M

Free cash flow minus SBC

$-29.5M

Gross profit

$-7.5M

Income taxes

$-5.3M

Investing cash flow

$-13.7M

Net borrowing

$-54,000

Net cash flow

$-4.9M

Net income

$-32.3M

Operating cash flow minus SBC

$-28.9M

Operating income

$-26.9M

Revenue

$13.1M

Stock-based compensation

$5.1M

Metric	Value
Altman Z-Score	-1.77
Book value per share	$0.24
Debt / equity	0.04
Goodwill	$10.7M
Long-term assets	$53.3M
Long-term liabilities	$38.4M
Net cash (debt)	$48.5M
Net cash / market cap	18.63%
Net cash growth	20.92%
Net debt / equity	-0.81
Piotroski F-Score	3
Property, plant and equipment	$4.5M
Shareholders' equity	$59.8M
Tangible book value	$18.5M
Tangible book value per share	$0.07
Total assets	$106.2M
Total cash	$50.8M
Total debt	$2.3M
Total liabilities	$46.4M
WACC	12.95%

Metric

Value

Altman Z-Score

-1.77

Book value per share

$0.24

Debt / equity

0.04

Goodwill

$10.7M

Long-term assets

$53.3M

Long-term liabilities

$38.4M

Net cash (debt)

$48.5M

Net cash / market cap

18.63%

Net cash growth

20.92%

Net debt / equity

-0.81

Piotroski F-Score

Property, plant and equipment

$4.5M

Shareholders' equity

$59.8M

Tangible book value

$18.5M

Tangible book value per share

$0.07

Total assets

$106.2M

Total cash

$50.8M

Total debt

$2.3M

Total liabilities

$46.4M

WACC

12.95%

Metric	Value
Asset turnover	0.13
Current assets	$53M
Current liabilities	$8M
Current ratio	6.61
Net working capital	$-4.9M
Quick ratio	6.46
Working capital	$45M
Working capital turnover	0.34

Metric

Value

Asset turnover

0.13

Current assets

$53M

Current liabilities

$8M

Current ratio

6.61

Net working capital

$-4.9M

Quick ratio

6.46

Working capital

$45M

Working capital turnover

0.34

Metric	Value
Buyback yield / dilution	-8.73%
Dividend yield	0%
Shareholder yield	-8.73%

Metric

Value

Buyback yield / dilution

-8.73%

Dividend yield

Shareholder yield

-8.73%

Metric	Value
10Y price change	-68.77%
10Y return CAGR	-10.33%
10Y total return	-66.38%
150-day SMA	$1.21
15Y price change	-79.12%
15Y return CAGR	-8.99%
15Y total return	-75.66%
1D price change	0.97%
1M price change	0.97%
1M total return	0.97%
1W price change	6.93%
1W total return	6.93%
1Y price change	-40.57%
1Y return CAGR	-40.59%
1Y total return	-40.57%
20-day SMA	$0.97
200-day SMA	$1.33
20Y price change	372.73%
20Y return CAGR	8.91%
20Y total return	450.88%
3M price change	0.97%
3M total return	0.97%
3Y price change	-7.96%
3Y return CAGR	-2.73%
3Y total return	-7.96%
50-day SMA	$1.02
50-day SMA vs 200-day SMA	50under200
52-week high	$2.09
52-week high date	2025-11-03
52-week low	$0.88
52-week low date	2026-10-01
5Y price change	-54.59%
5Y return CAGR	-14.61%
5Y total return	-54.59%
6M price change	-32.9%
6M total return	-32.9%
All-time high	$27.00
All-time high date	1997-10-31
All-time low	$0.10
All-time low date	2005-11-07
Average true range (ATR)	$0.06
Average volume	1.4M
Beta (1Y)	1.59
Beta (2Y)	1.19
Beta (5Y)	1.6
Change from 52-week high	-50.24%
Change from 52-week low	17.87%
Change from all-time high	-96.15%
Change from all-time low	940%
Change from open	2.46%
Day's gap	-1.46%
Dollar volume	$1M
High price	$1.04
Low price	$1.02
Monthly RSI	45.63
Open price	$1.02
Position in 52-week range	100%
Premarket change	-1.94%
Premarket close	$1.03
Premarket price	$1.01
Premarket volume	2.6K
Previous close	$1.03
Price vs 150-day SMA	-14.26%
Price vs 20-day SMA	7.5%
Price vs 200-day SMA	-21.98%
Price vs 50-day SMA	2.06%
Relative volume	0.7
RSI	57.05
Sharpe ratio	-0.73
Sharpe ratio (3Y)	0.27
Sharpe ratio (5Y)	0.07
Sortino ratio	-0.95
Sortino ratio (3Y)	0.51
Sortino ratio (5Y)	0.2
Volume	997.8K
Weekly RSI	41.82
YTD price change	-37.72%
YTD total return	-37.72%

Metric

Value

10Y price change

-68.77%

10Y return CAGR

-10.33%

10Y total return

-66.38%

150-day SMA

$1.21

15Y price change

-79.12%

15Y return CAGR

-8.99%

15Y total return

-75.66%

1D price change

0.97%

1M price change

0.97%

1M total return

0.97%

1W price change

6.93%

1W total return

6.93%

1Y price change

-40.57%

1Y return CAGR

-40.59%

1Y total return

-40.57%

20-day SMA

$0.97

200-day SMA

$1.33

20Y price change

372.73%

20Y return CAGR

8.91%

20Y total return

450.88%

3M price change

0.97%

3M total return

0.97%

3Y price change

-7.96%

3Y return CAGR

-2.73%

3Y total return

-7.96%

50-day SMA

$1.02

50-day SMA vs 200-day SMA

50under200

52-week high

$2.09

52-week high date

2025-11-03

52-week low

$0.88

52-week low date

2026-10-01

5Y price change

-54.59%

5Y return CAGR

-14.61%

5Y total return

-54.59%

6M price change

-32.9%

6M total return

-32.9%

All-time high

$27.00

All-time high date

1997-10-31

All-time low

$0.10

All-time low date

2005-11-07

Average true range (ATR)

$0.06

Average volume

1.4M

Beta (1Y)

1.59

Beta (2Y)

1.19

Beta (5Y)

1.6

Change from 52-week high

-50.24%

Change from 52-week low

17.87%

Change from all-time high

-96.15%

Change from all-time low

940%

Change from open

2.46%

Day's gap

-1.46%

Dollar volume

$1M

High price

$1.04

Low price

$1.02

Monthly RSI

45.63

Open price

$1.02

Position in 52-week range

100%

Premarket change

-1.94%

Premarket close

$1.03

Premarket price

$1.01

Premarket volume

2.6K

Previous close

$1.03

Price vs 150-day SMA

-14.26%

Price vs 20-day SMA

7.5%

Price vs 200-day SMA

-21.98%

Price vs 50-day SMA

2.06%

Relative volume

0.7

RSI

57.05

Sharpe ratio

-0.73

Sharpe ratio (3Y)

0.27

Sharpe ratio (5Y)

0.07

Sortino ratio

-0.95

Sortino ratio (3Y)

0.51

Sortino ratio (5Y)

0.2

Volume

997.8K

Weekly RSI

41.82

YTD price change

-37.72%

YTD total return

-37.72%

Metric	Value
Float	191.1M
Float percentage	75.54%
Shares change (QoQ)	0.11%
Shares change (YoY)	8.73%
Shares held by insiders	4.86%
Shares held by institutions	26.77%
Shares outstanding	252.9M
Short % of float	15.23%
Short % of shares	11.5%
Short ratio	20 days

Metric

Value

Float

191.1M

Float percentage

75.54%

Shares change (QoQ)

0.11%

Shares change (YoY)

8.73%

Shares held by insiders

4.86%

Shares held by institutions

26.77%

Shares outstanding

252.9M

Short % of float

15.23%

Short % of shares

11.5%

Short ratio

20 days

Lineage Cell Therapeutics, Inc. (LCTX)

Price

Financial snapshot

Fair-value bridge

Latest news · LCTX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LCTX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LCTX

Frequently asked questions